Rakesh K Chitkara

Substandard drugs: Who has skin in the game?

The US Centre for Disease Control and Prevention (CDC) recently raised the alarm when eye drops made by Global Pharma…

2 years ago

Time to boost India-US ties beyond business

US-India trade and business relations have seen steady growth despite geopolitical ups and downs. There has not been any serious…

2 years ago

Reimagining healthcare: Let us address the basics

Healthcare has never been as important as it is today. With India becoming the most populous country in the world,…

2 years ago

Pharmacy of the world under quality scanner

We have witnessed recent incidents around children in Gambia and Uzbekistan losing their lives after consuming Indian-made cough syrup. There…

2 years ago

India as an emerging vaccine powerhouse

“Convert challenges into an opportunities”: this has been the consistent message from prime minister Modi to the industry and bureaucracy.…

2 years ago

New US envoy pick can boost ties with India

On Wednesday, the Senate Foreign Relations Committee voted in favour of former Los Angeles Mayor Eric Garcetti to become ambassador…

2 years ago

Trust in India growth story and expansion of high-end jobs

It is a matter of pride that Tata, an Indian company, has signed a letter of intent to acquire the…

2 years ago

PM Modi’s tryst with Make-in-India vaccine

As covid stuck and in the absence of any vaccine or therapeutic solutions, India had to lock down the nation…

2 years ago

Digital Personal Data Protection Bill:<br>Delayed but in right direction 

One of the standout features of the draft data protection bill is the use of ‘she/her’ to define the individual…

3 years ago

Predictable price control key to success in healthcare

Prime Minister Narendra Modi announced the Make in India initiative from the ramparts of the Red Fort on 15 August 2014,…

3 years ago